Awarded
6505--Imatinib Mesylate Tablets
Awarded tounder 36E79722D0001 (source: SAM.gov award notice)• $14.0M
Overview
- Posted
- October 1, 2021
- Notice type
- Award Notice
Notice details
- Last updated
- Dec 4, 2025
- Award date
- Oct 1, 2021
- Award amount (SAM.gov award notice)
- $14.0M
Identifiers
- Solicitation number
- 36E79721R0042
- Notice ID
- b97fe077b26d4c80b85db602610821cf
- Award number (PIID)
- 36E79722D0001
Description
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79721R0042 for an unrestrictive procurement for IMATINIB MESYLATE TABLETS, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E79721R0042 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about August 17, 2021, with a tentative closing date of August 31, 2021. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: https://beta.sam.gov/. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Teresa Hussain. Questions can be e-mailed to: Teresa.Hussain@va.gov. The estimated annual requirements are as follows: Item Description Size Estimated Annual Requirements (BT) 1 IMATINIB MESYLATE 100MG TAB 90 7,182 2 IMATINIB MESYLATE 400MG TAB 30 24,905
Award Overview
Award Number
36E79722D0001
Award Amount (SAM.gov award notice)
$14.0M
Award Date
Oct 1, 2021
Awardee
Awardee UEI
GQLDJJ8AQNN5
Awardee CAGE Code
1HT23
Original Solicitation
Notice ID: b97fe077b26d4c80b85db602610821cf
Posted Date: Oct 1, 2021
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- —Signed Nov 18, 2026
- —Signed Nov 16, 2026
- —Signed Nov 10, 2026
- —Signed Nov 10, 2026
- —Signed Nov 6, 2026
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36E79721R0042- Pre-Solicitation
- Solicitation
- Awarded
This opportunity has been awarded.
- Pre-SolicitationJul 30, 2021
6505--Imatinib Mesylate Tablets
- 2×SolicitationAug 10, 2021
6505--Imatinib Mesylate Tablets
- AwardedCurrentOct 1, 2021
6505--Imatinib Mesylate Tablets
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36E79721R0042
Archive Date
Nov 30, 2021
Office Address
HINES, IL, 60141